ici 118551 and metaproterenol

ici 118551 has been researched along with metaproterenol in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arellano-Mendoza, MG; Correa-Basurto, J; Soriano-Ursúa, MA; Trujillo-Ferrara, JG; Valencia-Hernández, I	1

Other Studies

1 other study(ies) available for ici 118551 and metaproterenol

Article	Year
Synthesis, pharmacological and in silico evaluation of 1-(4-di-hydroxy-3,5-dioxa-4-borabicyclo[4.4.0]deca-7,9,11-trien-9-yl)-2-(tert-butylamino)ethanol, a compound designed to act as a beta2 adrenoceptor agonist. European journal of medicinal chemistry, 2009, Volume: 44, Issue:7 Topics: Adrenergic beta-2 Receptor Agonists; Albuterol; Animals; Binding Sites; Bridged Bicyclo Compounds; Butylamines; Computational Biology; Drug Design; Ethanol; Guinea Pigs; Humans; Ligands; Male; Models, Molecular; Molecular Conformation; Receptors, Adrenergic, beta-2; Trachea	2009

Article

Year

Synthesis, pharmacological and in silico evaluation of 1-(4-di-hydroxy-3,5-dioxa-4-borabicyclo[4.4.0]deca-7,9,11-trien-9-yl)-2-(tert-butylamino)ethanol, a compound designed to act as a beta2 adrenoceptor agonist.

European journal of medicinal chemistry, 2009, Volume: 44, Issue:7

Topics: Adrenergic beta-2 Receptor Agonists; Albuterol; Animals; Binding Sites; Bridged Bicyclo Compounds; Butylamines; Computational Biology; Drug Design; Ethanol; Guinea Pigs; Humans; Ligands; Male; Models, Molecular; Molecular Conformation; Receptors, Adrenergic, beta-2; Trachea

2009